Reference
Sharif, K.A., et al., Concentrating capacity of the human reduced folate carrier (hRFC1) in human ZR-75 breast cancer cell lines.
Biochem. Pharmacol. 55, 1683-1689, (1998)
abstract
Doyle, J.B., et al. Cell and Tissue Culture: Laboratory Procedures, 27D
Yao, R., et al., Human γ-glutamyl hydrolase: cloning and characterization of the enzyme expressed
in vitro.
Proc. Natl. Acad. Sci. USA 93, 10134-10138, (1996)
abstract
Jansen, G., et al., Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and -resistant leukemia cells.
Adv. Enzyme Regul. 37, 59-76, (1997)
abstract
Kumar, P., et al., Interaction of polyglutamyl derivatives of methotrexate, 10-deazaaminopterin, and dihydrofolate with dihydrofolate reductase.
Cancer Res. 46, 5020-5023, (1986)
abstract
Kumar, P., et al., Inhibition of human dihydrofolate reductase by antifolyl polyglutamates.
Biochem. Pharmacol. 38, 541-543, (1989)
abstract
Rhee, M.S., et al., Characterization of human cellular γ-glutamyl hydrolase.
Mol. Pharmacol. 53, 1040-1046, (1998)
abstract
Longo, G. S., et al., γ-Glutamyl hydrolase and folylpolyglutamate synthetase activities predict polyglutamylation of methotrexate in acute leukemias.
Oncol. Res. 9, 259-263, (1997)
abstract
reference
Aldrich MSDS 1, 54:D / Corp MSDS 1 (1), 129:B / FT-IR 2 (3), 3973:A / FT-IR 1 (2), 898:B / IR-Spectra (3), 1416:F / RegBook 1 (3), 3539:D / RegBook 1 (2), 2663:G / Sigma FT-IR 1 (2), 252:C / Structure Index 1, 419:B:1